Cargando…

Brain-Gut Interactions in IBS

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with an estimated prevalence of 10–20%. Current understanding of the pathophysiology of IBS is incomplete due to the lack of a clearly identified pathological abnormality and due to the lack of reliable biomarkers. Possible mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Fichna, Jakub, Storr, Martin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389673/
https://www.ncbi.nlm.nih.gov/pubmed/22783191
http://dx.doi.org/10.3389/fphar.2012.00127
_version_ 1782237339730313216
author Fichna, Jakub
Storr, Martin A.
author_facet Fichna, Jakub
Storr, Martin A.
author_sort Fichna, Jakub
collection PubMed
description Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with an estimated prevalence of 10–20%. Current understanding of the pathophysiology of IBS is incomplete due to the lack of a clearly identified pathological abnormality and due to the lack of reliable biomarkers. Possible mechanisms believed to contribute to IBS development and IBS like symptoms include physical stressors, such as infection or inflammation, psychological, and environmental factors, like anxiety, depression, and significant negative life events. Some of these mechanisms may involve the brain-gut axis (BGA). In this article we review the current knowledge on the possible involvement of the BGA in IBS and discuss new directions for potential future therapies of IBS.
format Online
Article
Text
id pubmed-3389673
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33896732012-07-10 Brain-Gut Interactions in IBS Fichna, Jakub Storr, Martin A. Front Pharmacol Pharmacology Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with an estimated prevalence of 10–20%. Current understanding of the pathophysiology of IBS is incomplete due to the lack of a clearly identified pathological abnormality and due to the lack of reliable biomarkers. Possible mechanisms believed to contribute to IBS development and IBS like symptoms include physical stressors, such as infection or inflammation, psychological, and environmental factors, like anxiety, depression, and significant negative life events. Some of these mechanisms may involve the brain-gut axis (BGA). In this article we review the current knowledge on the possible involvement of the BGA in IBS and discuss new directions for potential future therapies of IBS. Frontiers Research Foundation 2012-07-05 /pmc/articles/PMC3389673/ /pubmed/22783191 http://dx.doi.org/10.3389/fphar.2012.00127 Text en Copyright © 2012 Fichna and Storr. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Pharmacology
Fichna, Jakub
Storr, Martin A.
Brain-Gut Interactions in IBS
title Brain-Gut Interactions in IBS
title_full Brain-Gut Interactions in IBS
title_fullStr Brain-Gut Interactions in IBS
title_full_unstemmed Brain-Gut Interactions in IBS
title_short Brain-Gut Interactions in IBS
title_sort brain-gut interactions in ibs
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389673/
https://www.ncbi.nlm.nih.gov/pubmed/22783191
http://dx.doi.org/10.3389/fphar.2012.00127
work_keys_str_mv AT fichnajakub braingutinteractionsinibs
AT storrmartina braingutinteractionsinibs